Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-024956)

Filing Details

Accession Number:: 0001209191-15-024956
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-03-11 08:38:52
Reporting Period:: 2015-03-06

Filing Date:: 2015-03-11
Accepted Time:: 2015-03-11 08:38:52
Original Submission Date:: 2015-03-10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1564955	Greg Madison	C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022	President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-03-06	6,380	$12.53	110,043	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Form 4 originally filed on March 10, 2015 is being amended to revise Column 4 to state that the securities were acquired and not disposed of.
Includes 73,875 shares of restricted stock.